TrueBlue (TBI) Cash & Equivalents (2009 - 2026)

TrueBlue (TBI) has 18 years of Cash & Equivalents data on file, last reported at $24.1 million in Q1 2026.

• Quarterly Cash & Equivalents rose 4.65% year-over-year to $24.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.1 million (up 4.65% YoY) and the FY2025 annual result came in at $24.5 million, up 8.76% from the prior year.
• Cash & Equivalents fell to $24.1 million in Q1 2026 per TBI's latest filing, from $24.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $72.1 million in Q4 2022 and bottomed at $14.5 million in Q3 2024.
• The 5-year median for Cash & Equivalents is $32.4 million (2022), against an average of $35.5 million.
• The widest annual swing landed in 2023, when Cash & Equivalents soared 53.1%; it then slumped 69.21% in 2024.
• Tracing TBI's Cash & Equivalents over 5 years: stood at $72.1 million in 2022, then slipped by 14.11% to $61.9 million in 2023, then sank by 63.58% to $22.5 million in 2024, then grew by 8.76% to $24.5 million in 2025, then retreated by 1.54% to $24.1 million in 2026.
• Per Business Quant, the three latest TBI Cash & Equivalents figures stand at $24.1 million (Q1 2026), $24.5 million (Q4 2025), and $19.9 million (Q3 2025).

Peer Comparison